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test to compare the outcome of various management strategies in
each CAE type.
Results: 2539 Coronary angiograms were done in our hospital.
The incidence of CAE is 1.22% (N¼31).74.2% were male. The
mean age, body surface area, oxygen consumption and Low
Density Lipoprotein levels were 61.23±9.8years, 1.7±0.14m2,
202.9±33ml/min and 83.8±27.6mg/dl. No significant association
with diabetes mellitus or hypertension but negative association
with smoking [Likelihood ratio 0.032]. 77.5% of CAE had left
ventricle systolic function >40%. 13 (41.9%) patients underwent
CABG, 12 (38.7%) were on medical management and 5(16.1%)
had PCI. One patient had dilatation of ascending aorta along
with LAD ectasia and underwent Bentalls. Type I (50%, N¼5) & IV
(50%, N¼5) lesion were predominantly underwent CABG.
Whereas both type II (50%, N¼2) & III (42.9%, N¼3) were kept on
medical management. PCI was mostly the option for type III
(40%, N¼2) ectasia. Six months follow up showed no events in
any of the patients.
Conclusions: CAE has got over all good prognoses. There is no
association of diabetes or hypertension with Ectasia. But there is
negative association of smoking with Ectasia. Type II & III ectasia
can be put on medical management alone. Type I ectasia require
CABG.
Assessment of high sensitivity C-reactive protein
in ETT positive patients with normal coronary
angiogram
Md. Toufiqur Rahman, A.A.S. Majumder, Afzalur Rahman,
Mahboob Ali, Abdul Wadud Chowdhury
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Introduction: About 30% of coronary angiographies done for chest
discomfort and positive stress cardiac testing are normal. Patients
with chest pain with normal coronary arteries have coronary
microvascular endothelial dysfunction and myocardial ischemia.
Elevated hs-CRP levels have been related to atherogenesis and
endothelial dysfunction. Little is known whether low grade
chronic inflammation is a pathogenic mechanism.
Aims and objectives: To assess high sensitive CRP in patients of
typical chest pain with normal coronary arteries (cardiac Syn-
drome X).
Methods: Cardiac Syndrome - X patients were compared to con-
trols to see any difference of markers of inflammation in the form
of HS-CRP. 120 patients with 50 number of well matched controls
were studied. All the patients underwent baseline investigations,
ECG, ETT , Echocardiography and coronary angiographies. The
serum levels of hs-CRP were estimated.
Results: Among the study group (Group-1), the mean age was
48.12 (± 7.87) yrs and 47.48 (± 7.48) yrs among control group
(Groyp-2). In Group-1 , 96 ( 80%) were male and 24 (20%) were fe-
male. In Group-2 , 40 ( 80%) were male and 10 (20%) were female .
In Group-1, 60% had sedentary lifestyle, 60% were hypertensives,
and 50% were diabetics or IGT, 70% were smokers, 40% were
dyslipidemics, 30% had family history of CAD and 50%were obese.
and serum levels of hs-CRP were found to be significantly higher
in Group-1 than in Group-2 patients, (4.10 ± 2.74 mg/L vs 1.18 ± 0.9
6mg/L, p < 0.001).
Conclusion: hs-CRP levels are higher in patients of cardiac Syn-
drome-X, suggesting a chronic low grade inflammatory process.
Association of coronary artery disease and carotid
artery disease in patients with peripheral vascular
disease
Md. Toufiqur Rahman, Syed Azizul Haque, A.A.S. Majumder,
Afzalur Rahman
National Institute of Cardiovascular Diseases, Dhaka and Dinajpur
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Background: In the decade ahead, patients and primary care
physicians will increasingly recognize the clinical burden of pe-
ripheral arterial disease (PAD). As new advances in the treatment
of coronary artery disease continue to reduce mortality and
morbidity, caregivers will increasingly confront the problem of
concomitant “noncoronary” arterial disease. Cardiovascular phy-
sicians should assume a more proactive clinical role, along with
their vascular medicine colleagues, to encourage new therapeutic
opportunities for the treatment of arterial disease affecting mul-
tiple vascular beds. Multivascular therapeutic approaches are
needed because atherosclerosis has a common systemic patho-
genesis and simultaneously affects multiple circulations.
Objectives: Peripheral vascular disease patients are at high risk of
developing cardiovascular and cerebrovascular events. The aim of
this study was to see the association of Coronary artery disease
and Carotid artery disease in patients with Peripheral vascular
disease.
Methods: 2 50 (200 males and 50 females) patients with peripheral
vascular disease of lower limbs admitted in the National Institute
of Cardiovascular Diseases (NICVD), Dhaka between June 2012 to
July 2013. Coronary angiography and carotid Doppler study was
done in all patients during their hospital stay.
Results: 125 of 250 patients (50 %) had significant CAD and 50
patients (20%) had significant carotid artery lesion and 25 patients
(10%) had both. In patients with significant CAD, 75 patients of 125
(60%) had severe CAD (left main or triple vessel or proximal LAD
lesion). 13 patients (10.5%) had left main, 50 patients (40%) had
triple vessel disease and 12 patients (09.5%) had proximal LAD
lesion . Among the 25 patients with both lesion, 15 patients (60%)
had severe CAD of which 3 patient (12%) had left main, 4 patients
(16%) had triple vessel disease and 3 patients (12%) had proximal
LAD lesion. The percent of patients with severe CAD (left main, 3
vessel or proximal left anterior descending lesion) among those
with Carotid artery disease was higher compared to those without
Carotid artery disease.
Conclusions: Both or either Coronary artery disease and/ or Ca-
rotid artery disease are quite prevalent in patients with Peripheral
vascular disease. So, all peripheral arterial disease patients should
be investigated to see presence of any coronary artery disease or
carotid artery disease.
Neutrophil count and its correlation with short
term morbidity and mortality in patients with
acute coronary syndrome
B. Paul, P.K. Biswas, D. Sarkar, A. Konar, K. Sur
R G Kar Medical College, Kolkata, India
Background: Inflammation plays a key role in the development of
atherosclerosis and acute coronary syndromes, the most impor-
tant cause of sudden cardiac death. Certain inflammatory
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markers have been identified to be associated with increased
incidence of cardiovascular complications and death in patients
with ACS and increased severity of coronary artery lesion. Among
these biomarkers some have emerged to be potentially useful in
early risk assessment of patients with ACS, such as CRP, B type
natriuretic peptide, troponin T/I, interleukin 6, and white blood
cell (WBC) count and among these WBC count is the simplest.
Although total leukocyte count is an established prognostic
marker of ACS, there are limited studies for differential neutrophil
count and prognosis in ACS.
Methods: 202 consecutive patients admitted with a diagnosis of
ACS were evaluated by history and physical examination. Venous
blood was drawn from all the patients at the time of admission
and was analysed for CK-MB, Troponin T and Total leukocyte
count and differential leukocyte count. The neutrophil counts
were assigned into three categories, N1 (<70%), N2 (70-90%) andN3
(90%): Coronary angiography was carried out within 24 hours of
admission.
Results: The Neutrophil count ranged from 45% to 98%. The me-
dian neutrophil count was 78%; Smokers had a higher neutrophil
count than non-smokers. Neutrophil count also tended to be
higher in patients who died within 7 days (P<0.001). The devel-
opment of new CHF or shock was associated with a higher
Neutrophil count (P<0.001) Patients with a closed infarct-related
artery on angiography (TIMI grade 0 or 1 flow) had a higher
neutrophil count than did patients with an open artery (P<0.001).
The presence of angiographically apparent thrombus was asso-
ciated with a higher Neutrophil count than those without
thrombus. (82%, n¼28 versus 68%, n¼72) (p<.01)
Conclusion: The results of the present study confirm previous
observations that relate elevated WBC count to adverse clinical
outcomes in patients with ACS and further explore the patho-
physiology that underlies this relationship. In addition to the
worse clinical outcome, reduced patency and greater thrombus
burden seen in patients with an elevated Neutrophil count, these
patients had poorer downstream microvascular perfusion as
assessed with TIMI perfusion grade. It is possible that this
impaired myocardial perfusion reflects neutrophilemediated
endothelial dysfunction andmicrovascular plugging, as described
in animal models of ischemia-reperfusion.
Single nucleotide polymorphisms associated with
myocardial infarction in patients from Western
India: A genome wide association study
V.K. Shah, D. Saranath, K.K. Shalia, P.P. Pawar, J. Rayar,
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Background: Myocardial infarction (MI) is leading cause of death
worldwide. Moreover, in India the average age of acutemyocardial
infarction (AMI) has reduced to 50 indicating it as a grave public
health concern. The objective of our studywas to identify genomic
variants associated with AMI in patients from Western India in
genome wide association study (GWAS) and validating the iden-
tified single nucleotide polymorphisms (SNPs), using high-
throughput DNA microarray analysis.
Methods: Initially, 48 AMI patients and 48 controls were screened
for SNPs using Illumina human CVD55K beadchip, containing
approximately 50,000 human SNPs probes. The identified SNPs
were then further validated by genotyping additional 188 patients
and 196 controls using custom based Illumina’s VeraCode Gold-
enGate Genotyping Assay. PLINK software was used to perform
statistical analysis.
Results: On normalization and filtration of the preliminary
microarray data, 98 SNPs of 94 genes were identified associated
with AMI (odds ratio range of 1.84-8.85, p value 0.0486 to 0.00334).
Eight of these 98 SNPs reproduced association (p<0.05). The genes
associated with some SNPs encoded for the proteins linked with
blood coagulation, innate immunity, troponin complex and in-
flammatory pathways.
Conclusion: The study identified 8 SNPs associated with AMI
which may increase the susceptibility towards the disease in pa-
tients from Western India.
T peak e T end interval: Marker for arrhythmic
events at 30 days following ST elevation
myocardial infarction
Subrangshu Dey, John Roshan Jacob, Bobby John
Department of Cardiology, Christian Medical College, Vellore, India
Objectives: We aimed to analyze the effect of reperfusion of
infarct related artery on the TpTe interval determined on the
surface 12 lead ECG. We also studied the association of Major
adverse cardiac events (MACE) with repolarization abnormality on
the ECG.
Methods: Patients with new onset STEMI treated with thrombol-
ysis or primary/ rescue PCI were included. Digital ECGs at 50 mm/
sec speed and 20 mm/mV gain filtered at 0.50e150Hz were taken
before and after reperfusion therapy. TpTe interval wasmeasured
in leads with limited ST-segment deviation. All patients were
followed up at 30 days.
Results: From June 2013 to December 2013, total of 216 patients
were included of which 183 were males (85.1%). The mean age
was 54.86 years (range 24-80 years). One hundred and thirteen
patients underwent primary PCI (52.3%), 57 lysis (26.4%) and
remaining 46(21.3%) rescue PCI. Thirty day Mortality was 5.1 %
(11 patients). The pre TpTe interval was 84.50ms (IQR 80 - 100
ms) and the mean TpTe intervals reduced following interven-
tion; primary PCI (74.93ms, p <0.001), thrombolysis (72.76,
p<0.001) and rescue PCI groups (72.86 ms, p¼0.004). Of the 216
patients, 210 were followed up at 30 days. Six patients were lost
to follow up. Eleven patients died 11(5.1%) patients died. Pre
TpTe interval more than 100 ms predicted (OR 13.21, 95% CI 1.16
e 150.57) increased risk of arrhythmias (Ventricular Tachycardia
and Ventricular Fibrillation). However, it did not predict mor-
tality at 30 days (OR e 1.4, 95% CI e 0.28 e 6.84). After adjusting
for established risk factors, TpTe interval difference (pre e post)
was found to be significantly associated with duration of chest
pain and Killip class.
Conclusion: The TpTe interval was significantly reduced after
reperfusion therapy. Pre-reperfusion TpTe predicted the risk of
arrhythmias at 30 days. However, it did not predict subsequent
all-cause mortality and heart failure at 30 days.
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